Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Pro-Epanutin (fosphenytoin sodium) - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA
Notice type:
3rd Party Publications
Date:
29/08/2016
Problem Or Issue:
Important Safety Information communication from Pfizer Healthcare Ireland - Pro-Epanutin (fosphenytoin sodium): Medication Errors and Off-label Use in Children under 5 Years of Age.
Important Safety Information - Pro-Epanutin (fosphenytoin sodium)
« Back
Date Printed: 25/04/2024